WallStreetZenWallStreetZen

How to Buy Colgate Palmolive Co Stock

Colgate Palmolive Co

Colgate Palmolive Co is a household & personal product company located in New York, United States, which is part of the Consumer Defensive sector, and is traded under the ticker CL on the NYSE exchange.

Colgate Palmolive Co stock last closed at $86.71, down 0.05% from the previous day, and has increased 14.79% in one year. It has overperformed other stocks in the Household & Personal Products industry by 0.22 percentage points. Colgate Palmolive Co stock is currently +28.23% from its 52-week low of $67.62, and -4.05% from its 52-week high of $90.37.

There are currently 823.15M CL shares outstanding. The market value of CL is $71.38B. In the past 24 hours, 4.84M CL shares were traded.

How to Buy Colgate Palmolive Co Stock

Not sure how to invest in Colgate Palmolive Co stock? Here's how.
  1. Choose where to buy Colgate Palmolive Co stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Colgate Palmolive Co stock.
  2. Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Deposit money your investment account: Pick your method of payment and add your information.
  4. Research Colgate Palmolive Co stock: The Colgate Palmolive Co ticker symbol is CL. Is Colgate Palmolive Co stock a good investment? Should you buy shares of CL? How do CL's underlying business fundamentals look? Do top analysts think Colgate Palmolive Co is a good buy? Why has CL's stock price moved recently? (Hint: Our stock analysis website can help you understand if CL is a good stock to buy).
  5. Make your CL purchase: Decide if you will purchase CL shares at the current market price or use a limit order to purchase CL stock at a specific price.
  6. Keep tabs on your investment in CL: Create a watchlist to get the latest news on your new investment in Colgate Palmolive Co shares.

Step 1: Choose where to buy Colgate Palmolive Co stock

You will need an online brokerage account to access the NYSE market and buy CL shares.

A brokerage account is an investment account that enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best stock brokerage. eToro gives you:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global markets: From Tech to Real Estate, New York to Hong Kong — you can fill your portfolio with stocks from the world's leading stock exchanges.
  • Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your purchase of stock by opening an account with eToro now.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've chosen the right brokerage, it's time to fill out some personal information so you can invest in CL stock today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to open a new brokerage account.
  1. Submit your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your investment account

Now that you have filled out your info on the best beginner stock app, you need to deposit funds:

Check out the walkthrough below if you need help depositing money into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Colgate Palmolive Co stock

After you have chosen the best place to buy Colgate Palmolive Co stock, it's absolutely critical to research their stock prior to buying, so you can comprehend the risk as well as the opportunity.

Colgate Palmolive Co Numbers

CL Price
$86.71
1w %
0.83%
1y %
14.79%
5y %
25.03%
P/E
31.19x
P/B
117.2x
P/S
3.67x
PEG
1.38x
Revenue
$19.46B
Earnings
$2.30B
Fore. Rev. Growth
4.42%
Fore. Earn. Growth
22.58%
Market Cap
$71.38B
Next Earnings
Apr 26, 2024
Next Dividend
May 15, 2024

CL Zen Score

WallStreetZen was created to help everyday investors do more in-depth fundamental analysis quickly.

You can see all of the due diligence checks on CL's stock page.

How is CL stock valued?

You can use a variety of different financial metrics, analyses, models, and charts to gauge CL's true value.

Using relative valuations methods:

  • CL may be undervalued based on its P/E ratio of 31.19x, relative to Household & Personal Products industry P/E ratio of 34.94x
  • CL may be overvalued based on its P/B ratio of 117.2x, relative to Household & Personal Products industry P/B ratio of 7.21x
  • CL may be overvalued based on its PEG ratio of 1.38x

You can access additional valuation research on CL's stock here.

CL Financial Health Summary

Positive Financial Indicators:

  • CL earnings of $3.47B is not sufficient to cover its interest payments.
  • CL's operating cash flow of $3.75B allows it to safely service it's debt of $8.55B.
  • There are more short-term assets than short-term liabilities on the CL balance sheet.
  • CL profit margin has gone up from 9.9% to 11.8% in the past year.
  • Total CL debt is lower than 5 years ago, relative to shareholder equity.

Negative Financial Indicators:

  • There are more long-term liabilities than short-term assets on the CL balance sheet.
  • CL has a relatively high debt to equity ratio of 25.35.

Do Wall Street analysts think it's a good time to buy CL stock

Out of 13 sell side analysts who give forecasts on CL, the consensus analyst rating on CL is a Strong Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

Most Recent CL Analyst Recommendations

Dara Mohsenian, a top 3% analyst from Morgan Stanley maintains CL with a strong buy rating and raises their CL price target from $85.00 to $93.00, on Jan 29, 2024.

Morgan Stanley's Dara Mohsenian raised their price target on Colgate Palmolive Co (NYSE: CL) by 9.4% from $85 to $93 on 2024/01/29. The analyst maintained their Strong Buy rating on the stock.

Mohsenian called Colgate Palmolive's Q4 and FY 2023 earnings, reported on 2024/01/26, "an important confirmation point" that the company's topline growth is poised to inflect compared to peers."

The analyst argued that management's FY 2024 mid-to-high single-digit EPS guidance was "clearly too low."

Morgan Stanley reiterated Colgate Palmolive stock as its Top Pick in the consumer packaged goods group, Mohsenian added.

Earnings Report

Colgate Palmolive reported:

For Q4 2023:

  • EPS of $0.87, which beat the Zacks Consensus Estimate of $0.85 and, by 13%, Q4 2022's $0.77.
  • Revenue of $4.95B, which beat the Zacks Consensus Estimate of $4.898B and Q4 2023's $4.629B by 7%.

For FY 2023:

  • EPS of $3.23, up 8.8% from FY 2022's $2.97.
  • Revenue of $19.457B, up 8.3% from FY 2022's $17.967B.

For FY 2024, management guided:

  • Non-GAAP EPS to increase in the mid to high-single-digit range. GAAP EPS to increase in the double digits.
  • Revenue growth of 1% to 4%, including a low-single-digit negative FX impact.
  • Organic revenue growth within its long-term target range of 3% to 5%.
  • Gross profit margin expansion and increased advertising investment on both GAAP and non-GAAP bases.

Chairman, President & CEO Noel Wallace commented: “We are pleased to have finished the year with another quarter of strong top and bottom line results.

“For FY 2023, we grew both net and organic sales by 8.5%, with organic sales growth in every division and in all four of our categories. This was our fifth consecutive year with organic sales growth at or above our 3% to 5% targeted range.

“We continued to invest in the capabilities required to deliver robust growth going forward, building strength in areas like innovation, digital, data and analytics, revenue growth management and advertising.

"We leveraged our strong margin performance to invest in building our brands, with a 19% increase in advertising spending in FY 2023, and we expect higher levels of brand investment in FY 2024.

“The quality of our results this year and our strong growth momentum, including improved organic volume performance, add to our confidence that we are well positioned to deliver consistent, compounded earnings per share growth in FY 2024 and beyond.”

Peter Grom, a bottom 17% analyst from UBS maintains CL with a strong buy rating and raises their CL price target from $93.00 to $95.00, on Jan 29, 2024.

Chris Carey, a top 16% analyst from Wells Fargo maintains CL with a hold rating and raises their CL price target from $80.00 to $88.00, on Jan 29, 2024.

Olivia Tong, a top 5% analyst from Raymond James upgrades CL to a buy rating and announces their CL price target of $91.00, on Jan 29, 2024.

Andrea Teixeira, a top 12% analyst from JP Morgan maintains CL with a strong buy rating and raises their CL price target from $88.00 to $90.00, on Jan 18, 2024.

You can dive deeper into what analysts are forecasting on the Colgate Palmolive Co stock forecast page.

CL Technical Indicators

SMA10
86.75
SMA20
87.83
SMA50
86.91
SMA100
83.42
SMA200
78.8
MACD
-0.28
MACD Signal
0.01
MACD Histogram
-0.28
RSI
45.14
Stochastic %K
19.47
Stochastic %D
14.13
StochRSI %K
23.62
StochRSI %D
14.82

CL Revenue

Last year, CL earnings were $2.30B. During the past five year, CL's earnings have grown by 0.14% per year. This was slower than the Household & Personal Products industry average of 3.01%.

Last year, CL revenue was $19.46B. In the last five year, CL's revenue has increased by 4.59% per year. This was faster than the Household & Personal Products industry average of 4.32%.

Dig into CL's earnings and revenue performance here.

Latest Insiders Trades at CL

Over the last year, insiders at CL have sold more shares than they have bought.

John P. Bilbrey, Director of CL, was the latest CL insider to buy. They bought $21,206.40 worth of CL shares on Apr 1, 2024.

Research more about who owns CL shares here.

Does CL stock generate passive income?

Colgate Palmolive Co pays a dividend of 2.21%, compared to the Household & Personal Products industry's average dividend yield of 3.14%. If you owned $1,000 of CL stock, you would have received $22.14 last year.

Colgate Palmolive Co dividend payments have consistently grown over the past decade and have remained stable.

Find more analysis about Colgate Palmolive Co dividend yield and history here.

What others are saying about CL

One of the reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to find out what other investors have to say.

Step 5: Make your CL purchase

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are mostly fine.
  • Limit order: A limit order lets you buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at an exact price limit, use a limit order.

Press the Open button and eToro will execute your order.

If you want more assistance buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Keep tabs on your investment in CL

Now that you own some shares in CL, you'll want to keep up with your new shares.

Create a watchlist to track the latest developments regarding your CL stock.

CL Feed

How to Buy Stock in Colgate Palmolive Co

To summarize, here are the 6 steps you need to take to buy Colgate Palmolive Co stock right now:

  1. Choose where to buy Colgate Palmolive Co stock
  2. Open a brokerage account
  3. Deposit money your investment account
  4. Research Colgate Palmolive Co stock
  5. Make your CL purchase
  6. Keep tabs on your investment in CL

If you require a place to buy stocks, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get notifications regarding your new investment in Colgate Palmolive Co, create a watchlist today.

NYSE: CL
$86.71-0.04 (-0.05%)
Updated Apr 18, 2024
Open eToro Account
NYSE: CL
$86.71-0.04 (-0.05%)
Updated Apr 18, 2024
Open eToro Account

FAQ

How much does it cost to buy one Colgate Palmolive Co share?

As of Apr 18, 2024, it costs $86.71 to buy one share of Colgate Palmolive Co stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.115 shares of CL.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Colgate Palmolive Co stock?

According to 13 Wall Street analysts who monitor Colgate Palmolive Co, their consensus recommendation is to buy Colgate Palmolive Co stock.

What is the best way to buy Colgate Palmolive Co stock?

One way to place an order for Colgate Palmolive Co stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.